Michelle L Varney Selected Research

Michelle L Varney Research Topics

Disease

34	Neoplasms (Cancer) 03/2022 - 11/2002
21	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2003
11	Melanoma (Melanoma, Malignant) 12/2012 - 04/2002
10	Multiple Myeloma 03/2022 - 01/2017
9	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2009
3	Inflammation (Inflammations) 01/2020 - 01/2005
3	Osteolysis 05/2010 - 01/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 09/2010
2	Hypoxia (Hypoxemia) 11/2005 - 09/2002
1	Immunoglobulin Light-chain Amyloidosis 03/2022
1	Rare Diseases (Rare Disease) 03/2022
1	Adenocarcinoma 01/2019
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2016
1	Type 2 Diabetes Mellitus (MODY) 05/2009
1	Hemangiosarcoma (Angiosarcoma) 05/2009
1	Hyperlipidemias (Hyperlipidemia) 05/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2007
1	Prostatic Neoplasms (Prostate Cancer) 01/2007
1	Lymphatic Metastasis 10/2005
1	Infections 01/2005
1	Colonic Neoplasms (Colon Cancer) 01/2004
1	Carcinoma (Carcinomatosis) 01/2004

Drug/Important Bio-Agent (IBA)

11	LigandsIBA 01/2020 - 01/2003
9	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2002
8	Farnesyltranstransferase (Farnesyltransferase)IBA 02/2022 - 01/2017
7	Messenger RNA (mRNA)IBA 03/2014 - 09/2002
6	Interleukin-8B ReceptorsIBA 01/2020 - 01/2003
5	Chemokine ReceptorsIBA 01/2020 - 04/2010
5	ChemokinesIBA 01/2020 - 03/2003
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 09/2002
5	Interleukin-8 (Interleukin 8)IBA 01/2005 - 04/2002
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015 - 09/2002
4	Small Interfering RNA (siRNA)IBA 03/2014 - 10/2005
3	Pharmaceutical PreparationsIBA 03/2022 - 03/2016
3	TriazolesIBA 01/2021 - 11/2019
3	Diphosphonates (Bisphosphonates)IBA 01/2021 - 11/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 05/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 05/2013
3	Vascular Endothelial Growth Factor CIBA 01/2015 - 10/2005
2	Peptides (Polypeptides)IBA 03/2022 - 01/2007
2	EnzymesIBA 01/2021 - 10/2019
2	Terpenes (Terpenoids)IBA 01/2021 - 01/2021
2	CytokinesIBA 01/2020 - 01/2020
2	Semaphorins (Semaphorin)IBA 12/2018 - 09/2010
2	Antisense OligonucleotidesIBA 05/2010 - 01/2009
2	Transforming Growth Factor beta (TGF-beta)IBA 05/2010 - 01/2009
2	Neutralizing AntibodiesIBA 01/2009 - 11/2005
2	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2009 - 01/2009
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2005 - 10/2005
2	Conditioned Culture MediaIBA 11/2005 - 11/2002
2	Macrophage Colony-Stimulating FactorIBA 11/2005 - 11/2002
2	Capsaicin (Zostrix)FDA Link 09/2002 - 04/2002
2	NF-kappa B (NF-kB)IBA 09/2002 - 04/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2002 - 04/2002
1	melflufenIBA 03/2022
1	Alkylating AgentsIBA 03/2022
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 03/2022
1	AminopeptidasesIBA 03/2022
1	Amyloid (Amyloid Fibrils)IBA 03/2022
1	Proteasome InhibitorsIBA 02/2022
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Interleukin-17 ReceptorsIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Alkenes (Olefins)IBA 11/2019
1	CaspasesIBA 01/2019
1	IronIBA 01/2019
1	hydroxide ionIBA 01/2019
1	TropoloneIBA 01/2019
1	MucinsIBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2017
1	Histone Deacetylase InhibitorsIBA 09/2017
1	Protein Isoforms (Isoforms)IBA 12/2016
1	Biomarkers (Surrogate Marker)IBA 03/2014
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2012
1	AgarIBA 12/2012
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 05/2010
1	OligonucleotidesIBA 05/2010
1	AntigensIBA 08/2009
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2009
1	Troglitazone (Rezulin)FDA Link 05/2009
1	PPAR gammaIBA 05/2009
1	2- hydroxy- N,N- dimethyl- 3- (2- ((1- (5- methylfuran- 2- yl)propyl)amino)- 3,4- dioxocyclobut- 1- enylamino)benzamideIBA 04/2009
1	2-Hydroxypropyl-beta-cyclodextrinIBA 04/2009
1	SCH 479833IBA 04/2009
1	RANK LigandIBA 01/2009
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2009
1	Phosphotransferases (Kinase)IBA 01/2009
1	plexinIBA 01/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2007
1	Cell Adhesion MoleculesIBA 01/2007
1	Interleukin-8A Receptors (Receptors, Interleukin 8A)IBA 02/2006
1	Interleukin-8 ReceptorsIBA 01/2003
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 04/2002

Therapy/Procedure

11	Therapeutics 02/2022 - 01/2009
4	Drug Therapy (Chemotherapy) 01/2020 - 08/2007
1	Immunotherapy 08/2009
1	Stem Cell Transplantation 08/2007